Myeloproliferative Disorders
Reference98 articles.
1. Adamson, J. W. and Fialkow, P. J. (1978) The pathogenesis of myeloproliferative syndromes. Br. J. Haematol. 38, 299–303.
2. Adler, S. S. (1976) The pathogenesis of spleen mediated phenomena in chronic myeloid leukemia and agnogenic myeloid metaplasia: a nonabscopal mechanism. Scand. J. Haematol. 17, 153–159.
3. Aster, R. H. (1966) Pooling of platelets in the spleen: role in the pathogenesis of “hypersplenic” thrombocytopenia. J. Clin. Invest. 45, 645–657.
4. Aviram, M., Brook, J. G., Tatarski, I., Levy, Y., and Carter, A. (1986) Increased low-density lipoprotein levels after splenectomy: role for the spleen in cholesterol metabolism in myeloproliferative disorders. Am. J. Med. Sci. 291, 25–28.
5. Baccarini, M., Corbelli, G., Tura, S., and the Italian Group on Chronic Myeloid Leukemia (1981) Early splenectomy and polychemotherapy versus polychemotherapy alone in chronic myeloid leukemia. Leukemia Res. 5, 149–157.